Piper Sandler Downgrades Bausch Health Companies (BHC) to Underweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Wall Street ends down as oil prices, Treasury yields rise
- Anthropic's Claude AI identifies novel enzyme system in DNA search
- AppLovin (APP) on watch amid 3% drop premarket as boutique comments circulate
- Plug Power COO resigns to join another company
- Xtend AI Robotics wins Phase III of USSOCOM lethal drone program
Bausch Health Companies (BHC) PT Lowered to $8.50 at RBC Capital
August 2, 2024 6:22 AM EDTRBC Capital analyst Doug Miehm lowered the price target on Bausch Health Companies (NYSE: BHC) to $8.50 (from $10.00) while maintaining a Sector Perform rating.
The analyst comments "The operational performance of RemainCo was better than expected largely due to the strength in the... More
